Seguir
Félix Calderón
Félix Calderón
Dirección de correo verificada de gsk.com
Título
Citado por
Citado por
Año
Asymmetric aldol reaction using immobilized proline on mesoporous support
F Calderón, R Fernández, F Sánchez, A Fernández‐Mayoralas
Advanced Synthesis & Catalysis 347 (10), 1395-1403, 2005
1572005
Asymmetric aldol reaction catalyzed by a heterogenized proline on a mesoporous support. The role of the nature of solvents
EG Doyagüez, F Calderon, F Sanchez, A Fernandez-Mayoralas
The Journal of Organic Chemistry 72 (24), 9353-9356, 2007
1332007
A high throughput screen for next-generation leads targeting malaria parasite transmission
MJ Delves, C Miguel-Blanco, H Matthews, I Molina, A Ruecker, S Yahiya, ...
Nature communications 9 (1), 3805, 2018
1132018
An invitation to open innovation in malaria drug discovery: 47 quality starting points from the TCAMS
F Calderón, D Barros, JM Bueno, JM Coterón, E Fernández, FJ Gamo, ...
ACS Medicinal Chemistry Letters 2 (10), 741-746, 2011
932011
Open source drug discovery: highly potent antimalarial compounds derived from the tres cantos arylpyrroles
AE Williamson, PM Ylioja, MN Robertson, Y Antonova-Koch, V Avery, ...
ACS central science 2 (10), 687-701, 2016
872016
Antimalarial chemotherapy: natural product inspired development of preclinical and clinical candidates with diverse mechanisms of action: miniperspective
E Fernandez-Alvaro, WD Hong, GL Nixon, PM O’Neill, F Calderon
Journal of medicinal chemistry 59 (12), 5587-5603, 2016
752016
Synthesis of azasugars through a proline-catalyzed reaction
F Calderón, EG Doyagüez, A Fernández-Mayoralas
The Journal of Organic Chemistry 71 (16), 6258-6261, 2006
742006
CODES, a novel procedure for ligand-based virtual screening: PDE7 inhibitors as an application example
A Castro, MJ Jerez, C Gil, F Calderón, T Doménech, A Nueda, A Martínez
European journal of medicinal chemistry 43 (7), 1349-1359, 2008
592008
Origins of the double asymmetric induction on proline-catalyzed aldol reactions.
F Calderon, EG Doyagueez, PH Cheong, A Fernandez-Mayoralas, ...
The Journal of Organic Chemistry 73 (20), 7916-7920, 2008
512008
Antimalarial drug discovery: recent progress and future directions
F Calderón, DM Wilson, FJ Gamo
Progress in medicinal chemistry 52, 97-151, 2013
462013
A new in vivo screening paradigm to accelerate antimalarial drug discovery
MB Jiménez-Díaz, S Viera, J Ibanez, T Mulet, N Magan-Marchal, H Garuti, ...
PloS one 8 (6), e66967, 2013
432013
Development of Chemical Entities Endowed with Potent Fast-Killing Properties against Plasmodium falciparum Malaria Parasites
AN Matralis, A Malik, M Penzo, I Moreno, MJ Almela, I Camino, B Crespo, ...
Journal of medicinal chemistry 62 (20), 9217-9235, 2019
342019
Relative and Absolute Stereochemistry of Secondary/Secondary Diols:  Low-Temperature 1H NMR of Their bis-MPA Esters
F Freire, F Calderón, JM Seco, A Fernández-Mayoralas, E Quinoá, ...
The Journal of Organic Chemistry 72 (7), 2297-2301, 2007
302007
Carbamoyl triazoles, known serine protease inhibitors, are a potent new class of antimalarials
M McConville, J Fernández, Í Angulo-Barturen, N Bahamontes-Rosa, ...
Journal of medicinal chemistry 58 (16), 6448-6455, 2015
272015
Identification of Selective Inhibitors of Plasmodium N-Myristoyltransferase by High-Throughput Screening
A Harupa, L De Las Heras, G Colmenarejo, S Lyons-Abbott, A Reers, ...
Journal of Medicinal Chemistry 63 (2), 591-600, 2019
242019
A Divergent SAR Study Allows Optimization of a Potent 5-HT2c Inhibitor to a Promising Antimalarial Scaffold
F Calderón, J Vidal-Mas, J Burrows, JC de la Rosa, MB Jiménez-Díaz, ...
ACS Medicinal Chemistry Letters 3 (5), 373-377, 2012
242012
Synthesis and Structure–Activity Relationships of the Novel Antimalarials 5-Pyridinyl-4(1H)-Pyridones
JM Bueno, F Calderon, J Chicharro, JC De la Rosa, B Díaz, J Fernández, ...
Journal of Medicinal Chemistry 61 (8), 3422-3435, 2018
202018
Efforts aimed to reduce attrition in antimalarial drug discovery: a systematic evaluation of the current antimalarial targets portfolio
MJ Chaparro, F Calderón, P Castañeda, E Fernández-Alvaro, R Gabarró, ...
ACS Infectious Diseases 4 (4), 568-576, 2018
202018
A Developability-Focused Optimization Approach Allows Identification of in Vivo Fast-Acting Antimalarials: N-[3-[(Benzimidazol-2-yl)amino]propyl]amides
L Keurulainen, M Vahermo, M Puente-Felipe, E Sandoval-Izquierdo, ...
Journal of Medicinal Chemistry 58 (11), 4573-4580, 2015
172015
Expanding bromodomain targeting into neglected parasitic diseases
C Tallant, P Bamborough, C Chung, FJ Gamo, R Kirkpatrick, C Larminie, ...
ACS Infectious Diseases 7 (11), 2953-2958, 2021
132021
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20